PierianDx
About:
PierianDx is catalyzing global adoption of genomic sequencing in healthcare
Website: https://www.pieriandx.com
Twitter/X: pieriandx
Top Investors: RTI International, ARUP Laboratories, OrbiMed, Health Catalyst, Health Catalyst Capital
Description:
PierianDx is catalyzing global adoption of genomic sequencing in healthcare by empowering physicians in the laboratory and clinic to more effectively diagnose and treat patients with cancer and other complex diseases. PierianDx’s industry-leading genomic SaaS solutions, CAP and CLIA accredited laboratory, and shared knowledgebase are used by health systems, cancer centers and commercial laboratories worldwide driving the most integrated approach across the clinical care spectrum. From genomic sequencing and biomedical informatics in the laboratory to reporting and decision support at the patient’s bedside, PierianDx has rapidly become the trusted source of ‘wisdom’ in every advanced genomic report.
$74M
$10M to $50M
St Louis, Missouri, United States
2014-01-01
info(AT)pieriandx.com
Rakesh Nagarajan
51-100
2021-11-02
Private
© 2025 bioDAO.ai